August 7, 2026

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring an 18.56% Upside Potential

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a burgeoning player in the healthcare sector with a focus on rare diseases, has been capturing the attention of investors. With a market capitalization of..

Septerna, Inc. (SEPN) Stock Analysis: Unveiling Growth Potential with a 13.84% Upside

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, is making significant waves in the healthcare sector with its innovative approach to treating complex diseases. With a market capitalization of $1.78..

AtaiBeckley Inc. (ATAI): Investor Outlook with a 33.53% Potential Upside Amid Clinical Innovations

AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to mental health treatments. Despite recent financial challenges, the company’s robust..

Amylyx Pharmaceuticals (AMLX) Stock Analysis: Strong Buy Ratings and Promising Drug Pipeline Signal Growth Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has been garnering significant attention in the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With its current market cap standing at..

Fortrea Holdings Inc. (FTRE): Investor Outlook Reveals Potential 16% Upside in Biotechnology Sector

In the dynamic world of biotechnology, Fortrea Holdings Inc. (NASDAQ: FTRE) stands out as a promising player. Despite facing some challenges, the company’s potential for growth and innovation in the..

KalVista Pharmaceuticals (KALV) Stock Report: The Flat Line in Biotech Valuation

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotech sector, has captured investor attention with its recent transition from a public entity to a private subsidiary of Chiesi..

Butterfly Network, Inc. (BFLY) Stock Analysis: A High-Flying Medical Device Innovator with a 39.5% Revenue Growth

Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.21 billion, the company is at the..

Auna SA (AUNA) Stock Analysis: Healthcare Giant with a 34% Upside Potential

Auna SA (AUNA), a prominent player in the healthcare sector, is capturing investor interest with its impressive potential upside. As it navigates the medical care facilities industry, Auna operates a..

ArriVent BioPharma (AVBP) Stock Report: Exploring a 43.82% Potential Upside in the Biotech Arena

In the dynamic world of biotechnology, ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands out as a promising player, particularly for investors seeking high-growth opportunities in the healthcare sector. With a focus..

MBX Biosciences (MBX) Stock Analysis: Strong Buy Ratings and Significant Upside Potential

MBX Biosciences, Inc. (MBX), a promising player in the biotechnology sector, is gaining notable attention from investors with its robust pipeline of innovative therapies aimed at treating endocrine and metabolic..

Replimune Group, Inc. (REPL) Stock Analysis: A Biotech Play with a 1.09% Potential Upside

Replimune Group, Inc. (NASDAQ: REPL) has been capturing the attention of investors with its innovative approach to cancer treatment through oncolytic immunotherapies. As a clinical-stage biotechnology company, Replimune is at..

Sonida Senior Living, Inc. (SNDA) Investor Outlook: Exploring Growth Potential Amid 38.5% Revenue Surge

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector specializing in medical care facilities, is attracting investor attention with its impressive 38.5% revenue growth. As a company..

Altimmune, Inc. (ALT) Stock Analysis: Uncovering a 472% Potential Upside in the Biotechnology Sector

Altimmune, Inc. (NASDAQ: ALT), a prominent player in the biotechnology sector, is capturing investor attention with its robust potential upside of 472.17%, as indicated by analyst target price ranges. Specializing..

Geron Corporation (GERN) Stock Analysis: Exploring a 170.70% Potential Upside in the Biotech Arena

Geron Corporation (NASDAQ: GERN) stands at a pivotal moment in its evolution as a biopharmaceutical leader, capturing the attention of investors with its promising pipeline and significant market potential. With..

Maze Therapeutics, Inc. (MAZE): Investor Outlook on a Biotech Stock with 119% Potential Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company specializing in precision medicines for kidney and metabolic diseases, has captured the attention of investors with its promising pipeline and strong..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges with Strategic Staffing Solutions

Cross Country Healthcare, Inc. (CCRN) operates within the dynamic and essential healthcare sector, specifically focusing on medical care facilities. With a market capitalization of $428.06 million, the company plays a..

LifeMD, Inc. (LFMD) Stock Analysis: Unpacking the 186.76% Potential Upside

LifeMD, Inc. (NASDAQ: LFMD) presents a compelling opportunity for investors looking to tap into the burgeoning telehealth market. As a direct-to-patient telehealth company, LifeMD offers a range of virtual medical..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Contender with 17.99% Upside Potential

For investors with a keen eye on the healthcare sector, Enliven Therapeutics, Inc. (NASDAQ: ELVN) presents a compelling opportunity. This clinical-stage biopharmaceutical company, with a market cap of $4.42 billion,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Exploring Growth Prospects in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Alpharetta, Georgia, Avanos has carved out a niche..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges Amid Biotechnology Innovations

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) is a prominent player in the biotechnology industry, renowned for its pioneering work in cell engineering and biosecurity. As investors consider the potential opportunities..

Search

Funds

August 7, 2026

Search

Funds

August 7, 2026

FTSE 100

Funds